Acquired von Willebrand factor deficiency during high-dose infusion of recombinant factor VIII

British Journal of Haematology

Volumn 93, Issue 3, 1996, Pages 684-687

  Rock, G ^a,b   Adamkiewicz, T ^a   Blanchette, V ^a   Poon, A ^a   Sparling, C ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE   (Canada)

Author keywords

Acquired VSF deficiency; Recombinant factor VIII

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 8;

ARTICLE; BLOOD CLOTTING FACTOR DEFICIENCY; CASE REPORT; HEMOPHILIA A; HUMAN; INFANT; MALE; PRIORITY JOURNAL; VON WILLEBRAND DISEASE;

EID: 0029887496     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1683.x     Document Type: Article

References (15)

1. Brackmann, H.H. (1984) Induced immunotolerance in factor VIII inhibitor patients. Factor VIII Inhibitors (ed. by W. Doyer), pp. 181-195. Alan R. Liss, New York.
2. Brinkhous, K.M., Graham, J.E., Cooper, H.A., Allain, J.P. & Wagner, R.H. (1975) Assay of von Willebrand factor in von Willebrand disease and hemophilia: use of a macroscopic aggregation test. Thrombosis Research, 6, 267-272.
3. Cattaneo, M., Simoni, L., Gringeri, A. & Mannucci, P.M. (1994) Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factor. British Journal of Haematology, 86, 333-357.
4. Kasper, C.K., Aledort, L.M., Aronson, D., Counts, R.B., Edson, J.R., Fratantoni, J. & Green, D. (1975) A more uniform measurement of factor VIII inhibitors. Thrombosis et Diathesis Haemorrhagica, 34, 612.
5. Laurell, C.B. (1966) Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Analytical Biochemistry, 15, 45-52.
6. Lethagen, S., Berntorp, E. & Nilsson, I.M. (1992) Pharmacokinetics and hemostatic effect of different factor VIII/von Willebrand factor concentrates in von Willebrand's disease type III. Annals of Hematology, 65, 253-259.
7. Mannucci, P.M., Bettega, D. & Cattaneo, M. (1992) Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand's disease after repeated doses of desmopressin (DDAVP). British Journal of Haematology, 82, 87-93.
8. Martinowitz, U., Schulman, S., Gitel, S., Horozowitz, H., Heim, M. & Varon, D. (1992) Adjusted dose continuous infusion of factor VIII in patients with haemophilia A. British Journal of Haematology, 82, 729-734.
9. Rock, G. (1990) A comparison of two methods for the discrimination of VWF: Ag multimers. Thrombosis Research, 57, 817-824.
10. Rodeghiero, F., Castaman, G., Meyer, D. & Mannucci, P.M. (1992) Replacement therapy with virus-inactivated plasma concentrates in von Willebrand's disease. Vox Sanguinis, 62, 193-199.
11. Sadler, J.E. & Davie, E.W. (1987) The Molecular Basis of Blood Diseases (ed. by G. Stamatoyannopoulos, A. Nienhuis, P. Leder and P. Majerus), pp. 575-650. Saunders, Philadelphia.
12. Takeuchi, M., Naguza, H. & Kanedu, T. (1988) DDAVP and epinephrine induced changes in the localization of von Willebrand factor antigen in endothelial cells or human oral mucosa. Blood, 72, 850-854.
13. Tuddenham, E.G., Lane, R.S., Rotblat, F., Johnson, A.J., Snape, T.J., Middleton, S. & Kernoff, P.B. (1982) Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease. British Journal of Haematology, 52, 259-267.
14. Vicente, V., Estelles, A., Laso, J., Moraleda, J.L., Rivera, J. & Aznar, J. (1993) Repeated infusions of DDAVP induce low response of factor VIII and VWF but not of plasminogen activators. Thrombosis Research, 70, 117-122.
15. Weiss, H.J., Sussman, I.I. & Hoyer, L.W. (1977) Stabilization of factor VIII in plasma by the von Willebrand factor. Journal of Clinical Investigation, 60, 390-404.